Want to see IN:MKPL full AI Analyst Report?

M K Proteins Limited (MKPL) Price & Analysis

0 Followers

MKPL Stock Chart & Stats

₹6.89

-₹0.11(-1.36%)

At close: Jan 08 4:00 PM EST

₹6.89

-₹0.11(-1.36%)

Day’s Range― - ―

52-Week Range₹3.80 - ₹8.84

Previous CloseN/A

Volume181.52K

Average Volume (3M)20.59K

Market Cap

₹1.58B

Enterprise Value₹2.22B

Total Cash (Recent Filing)₹4.38M

Total Debt (Recent Filing)₹371.38M

Price to Earnings (P/E)23.9

Beta0.98

Next Earnings

Aug 18, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.18

Shares Outstanding375,372,000

10 Day Avg. Volume17,806

30 Day Avg. Volume20,591

Financial Highlights & Ratios

PEG Ratio-1.18

Price to Book (P/B)1.92

Price to Sales (P/S)0.38

P/FCF Ratio76.87

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Revenue ReboundFY2026 revenue growth of +17.7% indicates a durable demand recovery after prior declines. Sustained top-line improvement would allow the company to leverage fixed costs, provide more headroom to stabilize margins, and support working-capital and operational initiatives over the medium term.

Improved LeverageMeaningful deleveraging to a ~0.49 debt-to-equity ratio enhances financial flexibility and reduces refinancing risk. A lower leverage profile increases resilience to margin volatility and gives management more room to allocate capital or absorb shocks without immediate recourse to costly external funding.

Stronger Equity BufferRising equity and stable asset levels provide a deeper capital buffer to absorb shocks and support credit metrics. Improved equity cushions increase borrowing headroom and support medium-term investment capacity, making the balance sheet more robust versus prior years of higher leverage.

Bears Say

Margin CompressionSevere gross- and net-margin erosion to single-digit levels materially reduces the firm's ability to absorb input-cost inflation or competitive pricing pressure. Persistently thin margins constrain reinvestment in product, marketing, or efficiency programs and increase sensitivity to small revenue swings.

Weak Cash GenerationInconsistent and often negative operating cash flows show weak cash conversion versus reported earnings. Modest free cash flow limits capacity to fund growth, pay down debt, or withstand downturns, raising execution risk and forcing reliance on external financing if margins deteriorate again.

Declining Profitability TrendA falling net-income trend despite recent revenue growth suggests structural cost pressures or weakening pricing power. Continued earnings deterioration would erode retained earnings, constrain strategic investments, and impair the company's ability to restore sustainable profitability without substantive cost or pricing actions.

M K Proteins Limited News

M K Proteins Closes Trading Window Ahead of Q1 FY2026 Results

M K Proteins Limited ( ($IN:MKPL) ) has issued an announcement. M K Proteins Limited has announced the...

1M ago

MKPL

MKPL FAQ

What was M K Proteins Limited’s price range in the past 12 months?

M K Proteins Limited lowest stock price was ₹3.80 and its highest was ₹8.84 in the past 12 months.

What is M K Proteins Limited’s market cap?

M K Proteins Limited’s market cap is ₹1.58B.

When is M K Proteins Limited’s upcoming earnings report date?

M K Proteins Limited’s upcoming earnings report date is Aug 18, 2026 which is in 19 days.

How were M K Proteins Limited’s earnings last quarter?

M K Proteins Limited released its earnings results on May 29, 2026. The company reported ₹0.03 earnings per share for the quarter, beating the consensus estimate of N/A by ₹0.03.

Is M K Proteins Limited overvalued?

According to Wall Street analysts M K Proteins Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does M K Proteins Limited pay dividends?

M K Proteins Limited does not currently pay dividends.

What is M K Proteins Limited’s EPS estimate?

M K Proteins Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does M K Proteins Limited have?

M K Proteins Limited has 375,372,000 shares outstanding.

What happened to M K Proteins Limited’s price movement after its last earnings report?

M K Proteins Limited reported an EPS of ₹0.03 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of M K Proteins Limited?

Currently, no hedge funds are holding shares in IN:MKPL

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

M K Proteins Limited

M. K. Proteins Limited specializes in the production and commercial activities related to a range of refined vegetable oils and their associated derivatives. The company's diverse offerings include refined varieties such as rice bran, sunflower, cottonseed, soybean, palm, canola, and bleached rice bran oils. Furthermore, it provides by-products like rice bran fatty acid oils, rice bran waxes, gums, and spent earth. The firm also participates in the import and trade of both edible and non-edible oils. Founded in 2012, the company's operations are headquartered in Ambala, India.